ACE Report Cover
TKA: Better implant stability but comparable functionality with HA-coated tibial implants
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
言語
Download Download Download
ダウンロード
Cite this Report Cite this Report Cite this Report
引用
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ お気に入り
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
言語
Download Download Download
ダウンロード
Cite this Report Cite this Report Cite this Report
引用
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ お気に入り

ARTHROPLASTY

Hydroxyapatite (HA) coating appears to be of benefit for implant durability of tibial components in primary total knee arthroplasty

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(11):32 Acta Orthop. 2011 Aug;82(4):448-59. Epub 2011 Jun 10

寄稿者

JD Voigt M Mosier

This systematic review and meta-analysis identified 14 trials, which included 926 evaluable total knee arthroplasties. These studies examined the effect of hydroxyapatite (HA)-coating on tibial implant durability in primary total knee arthroplasty (TKA), in comparison other forms of tibial fixation. The primary outcomes in the selected studies were durability, function, and acute adverse events. Results indicated that the functionality between the types of implants were comparable, but durability with the HA-coated tibial implant may be better than other tibial implants in patients >65 years. There were no differences in adverse events between HA coated implants and other forms of tibial fixation.


出版資金提供の詳細 +
資金提供:
Not Reported
コンフリクト:
None disclosed

バイアスのリスク

9/10

報告基準

18/20

脆弱性指数

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

はい = 1

不確実=0.5

無関係 = 0

いいえ = 0

報告基準評価では、著者が出版物内で試験の方法論的特徴や試験特性を報告する際の透明性を評価します。評価は以下の5つのカテゴリーに分類されます。

4/4

Introduction

3/4

Accessing Data

4/4

Analysing Data

4/4

Results

3/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

Fragility Indexは、重要な所見の解釈を助けるツールで、結果の強さの尺度を提供します。Fragility Indexは、その所見が有意でなくなるために、二項対立の結果に追加する必要がある連続した事象の数を表します。数値が小さいほど弱い所見を表し、数値が大きいほど強い所見を表します。

なぜ今この研究が必要なのですか?

There is uncertainty on the clinical benefits of hydroxyapatite (HA)-coating in tibial components, as a part of total knee arthroplasty. HA-coatings on implants may promote greater stable fixation due to its osteoconductive properties, which promote early bone in-growth. This meta-analysis was conducted to evaluate the clinical outcomes (durability, function, and acute adverse events) in HA-coated tibial components in total knee arthroplasties.

主な研究課題は何ですか?

What are the clinical outcomes (durability, function, and acute adverse events) of hydroxyapatite (HA)-coated tibial components compared to other forms of tibial fixation in patients with knee osteoarthritis undergoing primary total knee arthroplasty measured at both short and long-term follow-up periods?

研究の特徴 +
データソース:
A search was conducted for published, prospective randomised controlled trials between 1990 to September 16, 2010 from internet databases and hand searches. Details of the literature search are not provided in the journal article, but is available on the Acta Orthopaedica website.
索引用語:
Not listed.
研究の選択:
Studies included were prospective randomised trials that examined the clinical outcomes (durability, function, and adverse events) of hydroxyapatite (HA)-coated tibial components or other tibial components (uncemented porous coated metal components, uncemented press-fit metal components, and cemented metal components (porous and non-porous coated)) in the shorter and longer terms. Two authors (JV and MM) screened the studies, and one author (JV) assessed the studies based on pre-specified inclusion/exclusion criteria.
データ抽出:
Identified studies had data independently extracted by one author (JV) and reviewed by another author (MM). Discrepancies were resolved through discussion or adjudication by an independent third party.
データ統合:
Data was assembled and reviewed using the Cochrane Review Manager software version 5.0.2. Random and fixed effects models were used, and heterogeneity was calculated using the I^squared statistic. Dichotomous outcomes were expressed as risk ratios (RR) with corresponding 95% confidence intervals (CI's), and continuous outcomes were expressed as mean differences.

重要な知見は?

  • At 2 years, tibial components coated with hydroxyapatite (HA) (porous or press-fit) without screw fixation were less likely to be unstable, compared to cemented and porous metal-backed tibial components (RR=0.58, 95%CI: 0.34-0.98; p=0.04, I2 = 39%, M-H random effects model)
  • No significant difference was seen in adverse events between groups (RR=1.20, 95%CI: 0.63-2.28; p=0.58; I2 =0%; Mantel-Haenszel (M-H) fixed effects model)
  • Evaluation at 2, and 8-10 years indicated no significant difference in durability between groups.
  • No significant difference was seen in functional status at 2 and 5 years, regardless of the type of measure used.
最も覚えておくべきことは?

Hydroxyapatite (HA)-coated implants may provide better implant stability in patients with osteoarthritis undergoing primary total knee arthroplasty (TKA), who are within the age range of 65-70 years, which may lead to a reduction in the need for revision later in the implant life. No difference was apparent in functionality between the HA-coated and other tibial implants, when measured by different validated scoring systems. No significant difference was seen in adverse events between groups.

それが私の患者ケアにどのように影響するか?

Trials with a larger population should be performed to determine the long-term outcomes of HA-coated implants and other porous-coated tibial implants, in younger (<65 years) and more active individuals with osteoarthritis.

免責事項

このページに記載されている内容は、情報提供のみを目的としたものであり、専門的な医療アドバイス、診断、治療の代わりとなるものではありません。治療が必要な場合は、必ず医師の診断を仰ぐか、最寄りの救急外来を受診してください。このページに記載されている内容に関して個人が表明した意見、信念、見解は、OrthoEvidenceの意見、信念、見解を反映するものではありません。

0の4 月間無料記事のロック解除
今月の無料記事閲覧数が4件に達しました。

週1.99ドルからOrthoEvidenceにアクセスできます。

最新のエビデンスにアクセスしてください。いつでもキャンセルできます。
  • 整形外科における最新のインパクトのあるランダム化比較試験とシステマティックレビューの批判的評価
  • Journal of Bone and Joint Surgeryとのコラボレーション、国際的に著名な外科医へのインタビュー、整形外科ニュースやトピックに関する座談会など、OrthoEvidenceポッドキャストコンテンツへのアクセス
  • 週2回発行されるエビデンスに基づくニュースレター、The Pulseの購読。
Upgrade
Close Dialog
おかえりなさい
パスワードをお忘れですか?
今すぐ無料トライアルを開始

あなたのアカウントは
OrthoEvidenceへの無料アクセスが含まれます。


または
パスワードをお忘れですか?

または
Eメールをご確認ください

入力されたメールアドレスにアカウントが存在する場合、パスワードリセットのメールが送信されます。メールが届かない場合は、迷惑メールフォルダをご確認ください。

その他のサポート サポートチームまでご連絡ください。.

この機能を有効にするにはログインしてください

この機能にアクセスするには、有効なOrthoEvidenceアカウントにログインする必要があります。ログインするか、無料トライアルアカウントを作成してください。

ACEレポートを翻訳

OrthoEvidenceは、多言語でコンテンツにアクセスできるようにするため、第三者の翻訳サービスを利用しています。正確性を確保するためにあらゆる努力をしていますが、翻訳が必ずしも完璧ではない可能性があることにご注意ください。

引用方法 ACE Report

OrthoEvidence. TKA: Better implant stability but comparable functionality with HA-coated tibial implants. OE Journal. 2013;1(11):32. Available from: https://myorthoevidence.com/AceReport/Show/tka-better-implant-stability-but-comparable-functionality-with-ha-coated-tibial-implants

引用のコピー
この機能を有効にするにはログインしてください

この機能にアクセスするには、有効なOrthoEvidenceアカウントにログインする必要があります。ログインするか、無料トライアルアカウントを作成してください。

プレミアム会員機能

この機能にアクセスするには、OrthoEvidenceのプレミアムアカウントにログインする必要があります。

共有 ACE Report